Established on the success of the SAPCS, the members of the resource project aim to determine the disease burden of prostate cancer within their respective regions. The overall objective, to provide the resources (from lifestyle and clinical data to biobanked biological specimens) aimed at providing region-specific recommendations for clinical management, driving local policy and awareness. Regional studies aim to identify both modifiable environmental or lifestyle risk factors for prostate cancer and aggressive disease, as well as molecular-genetic factors and mechanisms associated with prostate cancer risk, adverse outcomes and ethnic-based health disparities, to develop strategy for diagnosing, treating and preventing lethal disease.
-
East African Prostate Cancer Study (EAPCS)
Initiated in 2018, the EAPCS is managed out of the University of Nairobi in Kenya, in partnership with the University of Sydney in Australia. A co-funded member of HEROIC PCaPH Africa1K (since 2022), Directed by Prof Peter M. Ngugi, (University of Pretoria), Prof Vanessa Hayes provides Scientific Directorship (University of Sydney).
-
Southern African Prostate Cancer Study (SAPCS)
Initiated in 2008 with seed funding from the National Health and Medical Research Council (NHMRC) of South Africa, the SAPCS was established to provide a collaborative research infrastructure for clinical, epidemiological, and molecular-genetic studies aimed at understanding the aetiology of prostate cancer ethnic-based health disparities. In 2022, SAPCS became a co-funded member of HEROIC PCaPH…
-
Chicago Prostate Cancer Study (ChiPCS)
Initiated in 2022 as a con-founded member of HEROIC PCaPH Africa1K, ChiPCS is managed out of the University of Illinois at Chicago, with a focus on African American men. Directed by Professor Gail Prins, under the urological partnership of Dr Daniel Moreira and Dr Ikenna Madueke, ChiPCS is a partner study of the University of…